ALHC

Alignment Healthcare

Fundamental data last updated:April 13, 2026

company profile

SECTOR

Healthcare

industry

Healthcare Plans

Exchange

Nasdaq

County of HQ

United States

Next Earnings Date

04/30/26

Business Summary

Deluxe operates as a diversified business services and industrial-oriented conglomerate, generating cash by providing operational, marketing, and financial process solutions to a broad base of small and mid-sized businesses. Its moat is rooted less in innovation and more in entrenched customer relationships, recurring service revenues, and embedded workflows that create switching costs. Scale across multiple service lines allows it to cross-sell and spread fixed costs, supporting its 12.10% operating margin. Cash generation depends on disciplined cost control and maintaining relevance with business clients that rely on its infrastructure for everyday transactional and operational needs.

VALUATION

P/E

-

Market Cap ($M USD)

$4,188

Forward P/E

29.1

PEG

-

PRICE TO SALES

1

PRICE TO BOOK

23.4

EV / EBITDA

86.4

5-Year Average P/E

DIVIDEND

Yield

-

Annual Payout

-

Payout Ratio

-

Consecutive Years of Dividend Growth

0

5-Year Dividend Growth Rate

-

Financial Health & Profitability

Earnings Per Share

$0.00

Next Year EPS Growth Estimate

$0.70

Next Year Revenue Growth Estimate

25.10%

Return on Equity (ROE)

-0.40%

Operating Margin

0.40%

Debt-to-Equity

1.8

Piotroski F-Score

7

Altman Z-Score

5.7

Return on Invested Capital (ROIC)

2.50%%

Current Ratio

1.7

Quick Ratio

Gainseekers Quantitative Analysis

Summary

At 15.6x earnings and just 6.5x forward earnings, the market is clearly pricing in either a collapse in near-term profitability or balance sheet risk. The disconnect between a 15.6 P/E and 6.5 forward P/E suggests expectations of earnings compression, especially with EPS of 7.2 versus estimated next-year EPS of 1.83. The Altman Z-Score of 1.7 places the company in financial distress territory, meaning the discount is not arbitrary — it reflects solvency concerns. This is not a clean compounder; it is a statistically cheap, balance-sheet-sensitive cyclical trading at a valuation that screams skepticism rather than growth confidence.

AI Exposure / Tech Reliance

As an Industrials conglomerate, DLX operates in sectors where AI adoption is more incremental than transformative. Efficiency gains through automation and process optimization could support its 12.10% operating margin, but there is no data suggesting it is a technology leader. Its resilience will depend more on disciplined capital allocation than on disruptive innovation.

The Bull Case

A deep value investor will notice 0.6x sales and 1.9x book value — levels that suggest limited embedded growth expectations. A Piotroski F-Score of 7 signals solid underlying financial quality relative to distressed peers, and a 7.70% ROIC exceeding its 1.20% ROE implies operational returns that are stronger than equity returns would suggest. The 12.10% operating margin is respectable for an Industrials conglomerate, and a current ratio of 1 indicates liquidity is tight but not broken. Combined with a 2.2 TTM yield, this is the type of statistically cheap equity that could rerate sharply if earnings stabilize.

The Bear Case

The red flags are not subtle. An Altman Z-Score of 1.7 signals financial stress risk, and the dramatic drop from 7.2 EPS to 1.83 estimated next year explains the compressed 6.5 forward P/E — the market expects earnings deterioration. Debt/Equity at 12.10% is not extreme in isolation, but paired with a current ratio of 1, there is little liquidity cushion. The absence of a PEG ratio and 0.00% short interest suggest this is not a high-conviction growth story nor a heavily scrutinized battleground stock — it may simply be ignored for valid structural reasons.

Market Sentiment & Smart Money

Short Interest %

11.80%

Analyst Consensus

1.43

Average Analyst Price Target

$25.50

Institutional Ownership %

101.80%

1-Year Beta

0.67

Insider Buying % (6 Mo)

3.80%%

Distance to 52-Week High

85.90%%

Distance to 52-Week Low

176.30%%